SARAH KELLY: Open Payments
NPI 1659507564 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 53 payments from 9 companies in 2025. Trend: 2023 $1,049 · 2024 $705 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $264 |
| Amgen Inc. | 7 | $106 |
| UCB, Inc. | 2 | $40 |
| Organon LLC | 7 | $36 |
| Incyte Corporation | 2 | $31 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Botanix SB Inc | 1 | $16 |
Products named: SKYRIZI, OTEZLA, RINVOQ, BOTOX, Bimzelx, VTAMA, OPZELURA, Sotyktu.
Industry payments across MS — which companies pay providers there.
